<DOC>
	<DOCNO>NCT01724489</DOCNO>
	<brief_summary>Obesity important risk factor osteoporosis fracture . With grow prevalence obesity U.S. , understand pathophysiology bone loss population importance public health . Growth hormone ( GH ) critical mediator bone homeostasis markedly reduce obesity . Our preliminary data suggest important role GH/insulin-like growth factor 1 ( IGF-1 ) system pathogenesis bone loss obesity . The development novel image technique provide opportunity investigate effect GH skeletal structure strength , provide insight pathogenesis obesity relate bone loss . Understanding pathophysiology bone loss obesity may help identify new treatment target important complication . The investigator hypothesize low-dose GH administration 18 month improve skeletal health .</brief_summary>
	<brief_title>Study Growth Hormone Bone Obesity</brief_title>
	<detailed_description />
	<mesh_term>Obesity</mesh_term>
	<mesh_term>Bone Diseases , Metabolic</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<criteria>Ages 1865 generally healthy BMI ≥ 25 kg/m2 Bone mineral density ( BMD ) T score ≤ 1.0 &gt; 2.5 ( measure DXA ) For woman : amenorrhea 3 month , pregnancy breastfeeding , polycystic ovary syndrome History diabetes mellitus , cancer serious chronic disease Use osteoporosis medication Anemia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>